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Shift workers, who are exposed to irregular sleep sched-
ules resulting in sleep deprivation and misalignment of
circadian rhythms, have an increased risk of diabetes
relative to day workers. In healthy adults, sleep restriction
without circadian misalignment promotes insulin resis-
tance. To determine whether the misalignment of circa-
dian rhythms that typically occurs in shift work involves
intrinsic adverse metabolic effects independently of sleep
loss, a parallel group design was used to study 26 healthy
adults. Both interventions involved 3 inpatient days with
10-h bedtimes, followed by 8 inpatient days of sleep
restriction to 5 h with fixed nocturnal bedtimes (circadian
alignment) or with bedtimes delayed by 8.5 h on 4 of the
8 days (circadian misalignment). Daily total sleep time
(SD) during the intervention was nearly identical in the
aligned and misaligned conditions (4 h 48 min [5 min] vs.
4 h 45 min [6 min]). In both groups, insulin sensitivity (SI)
significantly decreased after sleep restriction, without a
compensatory increase in insulin secretion, and inflamma-
tion increased. In male participants exposed to circadian
misalignment, the reduction in SI and the increase in
inflammation both doubled compared with those who
maintained regular nocturnal bedtimes. Circadian mis-
alignment that occurs in shift work may increase diabetes
risk and inflammation, independently of sleep loss.
Worldwide in industrialized countries, nearly 20% of
working adults are shift workers (1–3). Prospective
epidemiologic studies indicate that shift work is associ-
ated with an increased risk of type 2 diabetes and cardio-
vascular disease (4–9). Shift work is generally associated
with chronic sleep loss, which adversely affects glucose
tolerance and cardiovascular function (10–13). Most shift
workers also have irregular sleep schedules, resulting in
circadian misalignment, a condition in which the behav-
ioral sleep–wake schedule and the feeding schedule are
not aligned with endogenous circadian rhythms. Be-
cause the timing of sleep and food intake synchronizes
a number of neural, endocrine, and metabolic rhythms,
whereas others remain locked to the master clock in the
suprachiasmatic nucleus (SCN) of the hypothalamus, cir-
cadian misalignment involves a lack of synchrony among
endogenous 24-h rhythms. Two recent laboratory studies
in which healthy participants were exposed to circadian
misalignment associated with reductions in total sleep
time provided causative evidence for a deleterious effect
on diabetes risk and cardiovascular function (14,15).
Whether circadian misalignment has adverse cardiometa-
bolic effects that are distinct from those imparted by
sleep loss is a fundamental and as yet unanswered ques-
tion with important implications for the health of mil-
lions of shift workers.
We therefore designed an experimental study in which
the major determinants of diabetes risk (insulin sensitivity
[SI] and b-cell function) as well as a predictor of cardio-
vascular risk (plasma levels of high-sensitivity C-reactive
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protein [hsCRP], an inflammatory marker [16–19]) were
compared in healthy adults under conditions of circadian
alignment versus misalignment, keeping the amount of
daily sleep identical.
RESEARCH DESIGN AND METHODS
Protocol and Participants
The protocol (Fig. 1) was approved by the University of
Chicago Institutional Review Board, where all participants
were studied after giving written informed consent.
We compared two 11-day interventions using a parallel
group design. For logistic reasons primarily related to
staffing, the two interventions could not be conducted
simultaneously. Therefore, the participants were not for-
mally randomized but assigned to the intervention that was
implemented at the time of their recruitment, without
being aware that there was an alternate intervention.
Participants from the local community responded to
advertisements inviting healthy adults with normal body
weight and ages 21–39 years to participate in a research
study, “Extended work schedules and health: Role of sleep
loss” and involving 2 weeks of hospitalization. Supplemen-
tary Figure 1 shows the flow diagram of subject recruit-
ment and participation. Participants underwent a physical
examination and laboratory tests to rule out endocrine,
psychiatric, and sleep disorders; medication use; smoking;
excessive alcohol or caffeine consumption; shift work or
travel across time zones during the past 2 months; and
self-reported habitual sleep of less than 7.5 h or more
than 8.5 h.
During 1 week before the study, subjects were asked to
comply with standardized schedules (2300–0700 h bed-
times). Compliance was verified with wrist activity record-
ings (Actiwatch, Mini-Mitter Co.). In women, the study
was initiated during the early follicular phase of the men-
strual cycle.
The interventions (Fig. 1) involved 3 days with 10-h
bedtimes (2200–0800 h: B1–B3; baseline rested condi-
tion), followed by 8 days with 5-h bedtimes (R4–R11),
with bedtimes always centered at 0300 h (0030–0530 h,
circadian alignment) or with bedtimes delayed by 8.5 h on
4 days (0900–1400 h on days R5–R6 and R8–R9; circa-
dian misalignment). Both interventions involved the same
amount of bedtime restriction, representing 24 h of lost
sleep opportunity over 8 days and were followed by 3
nights of recovery sleep.
An intravenous glucose tolerance test (IVGTT) was
performed after an overnight fast at 0900 h on B2 and
R10. Frequent blood sampling by an intravenous catheter
was performed during B3 and R11. Levels of hsCRP were
measured at 4-h intervals. Saliva samples for melatonin
assays were obtained every 30 min, from 1600 h until
bedtime, on R4 and R11.
Each participant met with a dietitian before the study
to determine food preferences and select three nutrition-
ally balanced menus that were served on a rotating
Figure 1—Schematic representation of the study design. The protocol followed a parallel group design with two experimental interventions:
sleep restriction with circadian alignment (left) and sleep restriction with circadian misalignment (right). The black bars represent the periods
allocated to sleep. In both groups, 3 baseline days of 10-h bedtimes (from 2200 to 0800 h; B1, B2, B3) were followed by 8 days of sleep
restriction to 5-h bedtimes (R4–R11). In the circadian alignment group, all short sleep periods were centered at 0300 h (bedtimes: 0030 to
0530 h). In the circadian misalignment group, four of the eight short sleep periods (R5, R6, R8, and R9) were delayed by 8.5 h, such that
sleep occurred during the daytime (0900 to 1400 h). In both groups, breakfast (B) was served between 0730 and 0830 h, lunch (L) between
1300 and 1400 h, and dinner (D) between 1900 and 1930 h. On shifted days in the misalignment group, lunch was served at 1500 h, 1 h after
wakeup time, and a sandwich (S) was presented at 0100 h. Snacks were available at all times. An IVGTT was performed at 0900 h on B2 and
on R10. Two 24-h sessions of blood sampling at 15- to 30-min intervals were performed on B3 and R11 (dashed lines). Caloric intake during
these sessions was limited to three identical carbohydrate-rich meals (HC). No snacks were allowed. Saliva sampling at 30-min intervals was
performed from 1600 to 0030 h on R4 and R11 to assess melatonin levels (gray bars).
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basis. On blood sampling days (B3 and R11), identical
carbohydrate-rich meals were served at 1400, 1900, and
0900 h and were completely ingested within 20 min. No
other caloric intake was allowed on these 2 days. During
the entire protocol, participants abstained from caffein-
ated beverages.
Sleep Data
Polygraphic sleep recordings (Neurofax EEG-1100A; Nihon
Kohden, Foothill Ranch, CA) were scored visually at 30-s
intervals in stages wake, I, II, slow-wave sleep (SWS) and
rapid-eye-movement (REM) sleep, according to standard-
ized criteria (20). Total sleep time was defined as minutes
of stages I + II + SWS + REM.
IVGTT
After three baseline samples, glucose (0.3 g/kg) was ad-
ministered intravenously. Blood samples were taken at
minutes 2, 3, 4, 5, 6, 8, 10, 12, 15, 19, 21, 22, 24, 26, 28,
30, 40, 50, 60, 70, 90, 100, 120, 140, 180, 210, and
240 after the glucose injection. At minute 19, insulin
(0.02 units/kg) was administered intravenously. Minimal
model analyses (21) were performed using the Minmod
Millennium software (22) and provided SI, the acute in-
sulin response to glucose (AIRg), a measure of b-cell re-
sponse, and the disposition index (DI = AIRg 3 SI),
a marker of diabetes risk.
One woman experienced hypoglycemia during her
baseline IVGTT. Her IVGTT data were not included in
the analysis.
Assays
Glucose concentrations were assayed at bedside (Model
23A; Yellow Springs Instrument Company, Yellow Springs,
OH). Serum insulin and hsCRP concentrations were
measured using IMMULITE high-sensitivity chemi-
luminescence assays (Diagnostic Products Corp.).
Melatonin was assayed in saliva and in serum by
radioimmunoassay (Pharmasan Labs, Inc., Osceola, WI),
with a limit of sensitivity of 3.5 pg/mL and an intra-assay
coefficient of variation of 8%.
Circadian Phase
Circadian phase was determined by the “dim light melatonin
onset” (DLMO) in saliva samples. Melatonin onset was de-
fined as the first sample to exceed a threshold of 2 SD above
the mean of the first three baseline samples (2000–2100 h)
not followed by a return below this threshold. Light inten-
sity was ,50 lux at eye level. When the DLMO did not
occur before bedtime, it was derived from serum levels for
both study conditions. These estimations were made before
the first (R4) and last (R11) short sleep periods.
hsCRP Levels
Seven determinations of hsCRP at 4-h intervals were
obtained at baseline and at the end of sleep restriction.
There were no consistent within-subject temporal variations,
and therefore, we used the median of the seven values as
a summary measure.
Statistical Analysis
Results are expressed as mean (SD) for normally distrib-
uted data or as median (25th, 75th percentile) otherwise.
Data were log-transformed where applicable.
To examine the effect of sleep restriction within each
group, cardiometabolic variables were submitted to repeated-
measures ANOVA.
Because of well-documented sex differences in the
regulation of sleep (23,24), circadian rhythms (25), and
glucose metabolism (26), sex was entered as a covariate in
analyses comparing the two interventions. We examined
the percentage change from baseline to the end of sleep
restriction by using a factorial ANOVA with intervention,
sex, BMI, and the interaction sex-by-intervention as factors
for all cardiometabolic variables. All statistical calculations
were performed using JMP software (SAS Institute Inc.,
Cary, NC).
RESULTS
Twenty-six participants completed the study, 13 in the
circadian alignment group and 13 in the circadian mis-
alignment group. The flow chart of enrollment is shown
in Supplementary Fig. 1, and Table 1 summarizes demo-
graphic data.
Sleep
At baseline, total sleep time and amounts of SWS and
REM sleep were similar in the two groups (Table 1, see
Fig. 2 for daily total sleep time). Our experimental strat-
egy (Fig. 1) consisted of increasing sleep pressure using
a first aligned night of bedtime restriction to achieve sim-
ilar levels of total sleep time during the period of bedtime
restriction, irrespective of the presence or absence of cir-
cadian disruption. This strategy was successful, because the
difference in total sleep time achieved during the seven
periods of short sleep undisturbed by blood sampling av-
eraged 22 min (i.e., ;3 min per bedtime period; Table 1
and Fig. 2).
Consistent with previous studies (27,28), SWS was bet-
ter preserved than REM sleep when bedtimes were re-
stricted. Amounts of SWS and REM sleep were similar
in both groups at baseline and during the 1-week inter-
vention (Table 1).
Circadian Phase
Participants in the circadian alignment protocol (Fig. 3)
experienced a nonsignificant delay of the DLMO of
30 min (0, 60) whereas those exposed to circadian mis-
alignment had a delay of 3 h 08 min (2 h 00 min, 3 h
30 min; P = 0.001). Of note, two men exposed to circadian
misalignment did not shift circadian phase. The remaining
11 subjects shifted by 3 h 30 min (2 h 23 min, 3 h 38 min).
Weight Change and Caloric Intake
Participants were free to help themselves ad libitum
during meals and had unlimited access to various snack
items. In the circadian alignment group, breakfast was
served between 0700 and 0830 h, lunch between 1300
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and 1330 h, and dinner between 1830 and 1930 h. In the
circadian misalignment group, on the days when bedtimes
were scheduled during the day (R5–R6, R8–R9), a light
meal (usually a sandwich) was served at 0100 h. A normal
breakfast was served in the morning. Lunch was served at
1500 h and dinner was served between 1830 and 1930 h.
Thus, there were only minimal differences in the timings of
breakfast, lunch, and dinner between the two groups.
The two groups consumed excessive but almost identical
amounts of calories, averaging 4,061 (971) Kcal/24 h
when bedtime periods were aligned and 4,058 (888)
Kcal/24 h when bedtime periods were misaligned. On
average, daily caloric intake during sleep restriction in-
cluded 62.8% (11.3%) carbohydrates, 33.0% (3.9%) fat, and
10.4% (2.1%) protein in participants in the aligned condi-
tion compared with 57.2% (5.2%) carbohydrates, 34.6%
(3.8%) fat, and 10.8% (1.8%) protein in participants in
the misaligned condition. None of the differences between
the two conditions were significant (P . 0.115). On aver-
age, during the 7 days of sleep restriction, the proportion
of calories consumed after 1900 h was 7% (4%) in the
aligned condition versus 21% (8%) in the misaligned con-
dition (P, 0.001). Weight gain was significant (P# 0.002)
and similar in both groups (Table 1).
Cardiometabolic Variables
SI decreased in 24 of the 25 participants after 7 days of
sleep restriction. The findings were qualitatively similar in
Table 1—Demographics and sleep variables
Circadian alignment Circadian misalignment
n = 13 n = 13 P level
Demographics
Sex
Female (n) 3 4
0.66
Male (n) 10 9
Age (years) 23 (21.5, 25.5) 22 (21.5, 24.5) 0.60
Weight at baseline (kg) 70.7 (11.0) 67.1 (11.3) 0.42
Baseline BMI (kg/m2) 23.1 (2.4) 22.2 (2.5) 0.34
Weight gain during study (kg) +1.4 (1.1) +1.6 (1.5) 0.71
Sleep*
Baseline
Total sleep time 9 h 06 min (8 h 47 min, 9 h 22 min) 9 h 05 min (8 h 07 min, 9 h 14 min) 0.54
SWS (min) 70 (20) 64 (31) 0.56
REM sleep (min) 127 (24) 122 (27) 0.64
During bedtime restriction
Total sleep time 4 h 48 min (5 min) 4 h 45 min (6 min) 0.22
SWS (min) 85 (68, 94) 68 (63, 89) 0.60
REM sleep (min) 64 (14) 59 (12) 0.31
Data are expressed as mean (SD) when normally distributed and as median (25th, 75th percentile) when not normally distributed. Data
were log-transformed when not normally distributed, and P levels were calculated using a t test. *Baseline sleep determined as mean of
B1 and B2 and bedtime restriction as mean of R4–R10.
Figure 2—Total sleep times achieved on each day for both study groups. Represented values are mean (SEM).
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both groups, in that a robust decrease in SI was not
compensated for by a commensurate increase in b-cell
responsiveness (as assessed by AIRg), and therefore, the
DI was decreased, consistent with an increased risk of
diabetes (Table 2). Median hsCRP levels were higher af-
ter sleep restriction than at baseline in both groups, but
the difference was significant for the misaligned group
only (Table 2). These findings were similar when analyses
were adjusted for weight change.
To examine the effect of the two interventions, we
compared the percentage change in cardiometabolic vari-
ables between the two groups (individual data in Fig. 4).
After controlling for BMI, the interaction sex-by-intervention
for percentage change in SI was234% (23%) in the aligned
group (n = 12) versus247% (20%) in the misaligned group
(n = 13), which was significantly different (P = 0.026). This
interaction was not significant for percentage change in
insulin secretion (+28% [55%] vs. +18% [36%], P = 0.16),
DI (217% [39%] vs. 239% [27%], P = 0.66), or hsCRP
(+50% [67%] vs. +119% [110%]; P = 0.63). Because of
the small number of women, the remainder of the analysis
included only men (individual data in Fig. 4). Figure 5
illustrates the glucose and insulin temporal profiles during
the IVGTT under rested condition and after sleep restric-
tion for the aligned and misaligned groups, and Fig. 6
reports the changes in the summary measures derived
from the IVGTT. Importantly, total sleep time for men
only was not significantly different between the two groups
during the sleep restriction period when baseline levels
were controlled for (P = 0.30). The relative decrease in SI
in men was nearly twice as large in the misaligned than in
the aligned group (258% [13%] vs. 232% [25%], P =
0.011; Fig. 6). There were no compensatory increases in
AIRg in either intervention group (+24% [39%] vs. +21%
[56%], P = 0.66; Figs. 5 and 6). Therefore, the reduction in
DI, reflecting an increase in diabetes risk, tended to be
greater after circadian misalignment than when the sleep–
wake cycle remained aligned (248% [24%] vs.219% [43%],
P = 124; Fig. 6). Increases in hsCRP after sleep restriction
were higher in the misaligned than in the aligned groups
(+146% [103%] vs. +64% [63%], P = 0.049; Fig. 6) in male
participants. Interestingly, these hsCRP increases were
correlated with the shift in circadian phase, as estimated
by melatonin onset (r = 0.487, P = 0.040).
Figure 3—Assessments of circadian phase. Timing of DLMO before the first (●) and before the last (○) short sleep periods. The circadian
phase could not be determined for one subject in the circadian misalignment group.
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In women, differences in IVGTT and hsCRP variables
between the aligned and misaligned intervention were
nonsignificant.
DISCUSSION
We designed the current study to determine whether
circadian misalignment has adverse cardiometabolic
effects independently of sleep loss. Our experimental
strategy was successful, because the participants obtained
nearly identical amounts of sleep irrespective of exposure
to circadian alignment or misalignment. Sleep loss re-
duced SI and DI, but the reduction in SI was nearly twice
as large when the week of sleep restriction included 4 days
with bedtimes delayed by 8.5 h than when the center of
the sleep period remained fixed. Despite the greater
decrease in SI in participants exposed to circadian mis-
alignment, the b-cell response was similar to that ob-
served in participants in whom synchrony between
Table 2—Cardiometabolic variables for both study groups
Baseline Sleep restriction (after 7 nights of sleep restriction) P level
Circadian alignment (n = 12)
SI ([mU/L]21 $ min21) 6.6 (4.2, 9.7) 4.0 (3.1, 5.5) ,0.001
AIRg (mU $ L21 $ min) 345 (267, 466) 456 (283, 555) 0.22
DI 1,940 (1,602, 3,161) 1,579 (1,152, 2,195) 0.075
hsCRP 0.048 (0.028, 0.161) 0.080 (0.042, 0.156) 0.061
Circadian misalignment (n = 13)
SI ([mU/L]21 $ min21) 6.2 (5.8, 8.1) 2.9 (2.2, 4.7) ,0.001
AIRg (mU $ L21 $ min) 346 (276, 610) 385 (249, 720) 0.175
DI 2,146 (1,487, 3,737) 1,088 (690, 2,378) ,0.001
hsCRP (n = 10) 0.031 (0.017, 0.047) 0.057 (0.028, 0.112) 0.007
Data are expressed as median (25th, 75th percentile) and are log-transformed to meet the assumptions of repeated-measures ANOVA.
Figure 4—Individual changes in cardiometabolic variables. Values represent percentage change from baseline of SI, AIRg, DI, and hsCRP.
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behavioral and endogenous rhythms was maintained.
These findings demonstrate that circadian misalignment
can have adverse effects on insulin action and insulin release
that are distinct from those imparted by sleep loss alone.
Similarly, the levels of hsCRP, a marker of systemic inflam-
mation and a predictor of cardiovascular disease risk, were
increased after sleep restriction and to a greater extent in
the participants who experienced circadian misalignment.
Figure 5—Temporal profiles of glucose (top) and insulin (bottom) levels during IVGTT. Mean (SD) glucose and insulin levels during IVGTT
performed under baseline (i.e., rested) condition and after 7 days of sleep restriction to 5 h per day for the men in the circadian alignment
(n = 10) and the circadian misalignment (n = 9) groups. Visual examination of these profiles suggests that the effect of sleep restriction on
the decline of glucose concentrations is greater in the presence of circadian misalignment despite higher levels of insulin, consistent with
a greater decrease in SI. Minimal model analysis of individual profiles confirmed this visual impression.
Figure 6—Changes in cardiometabolic variables in male participants. Mean (SD) changes in SI, AIRg, DI, and hsCRP from baseline to sleep
restriction are shown in both intervention groups. *P < 0.05.
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Our protocol involved restricting bedtimes to build
sleep pressure and thereby achieving virtually identical
amounts of sleep in both arms of the study. Thus, we
controlled experimentally for total sleep time, and caloric
intake was also nearly identical in both arms of the
protocol. We concluded that circadian misalignment has
intrinsic adverse cardiometabolic effects. A study design
where bedtimes would not have been restricted would
have led to a greater amount of sleep loss in the circadian
misalignment group, with a need to control statistically
for total sleep time in the analysis, as performed in the
only previous experimental study that attempted to
demonstrate adverse cardiometabolic effects of circadian
misalignment (14). In this previous study, total sleep time
varied according to the degree of misalignment, and the
conclusion that circadian misalignment has adverse cardi-
ometabolic consequences relied on the statistical signifi-
cance of alignment versus misalignment while controlling
for sleep efficiency as a covariate in the statistical analysis.
The current study provides instead a direct experimental
demonstration.
The shift in circadian time could have influenced our
estimations of the magnitude of the change in SI between
the aligned and misaligned conditions. This issue was
carefully considered when the protocol was designed.
Indeed, a phase delay was used rather than a phase advance
to create circadian misalignment. In healthy nonobese
individuals, SI is higher in the morning than 8 to 10 h
later, in the late afternoon or early evening (29). Our par-
ticipants in the circadian misalignment condition experi-
enced a delay of the melatonin onset of about 3 h, but
the clock time of the IVGTT remained fixed at 0900. There-
fore, relative to internal circadian time, SI was assessed
earlier—rather than later—in the biological day. In addi-
tion, there is evidence that peripheral clocks in metabolically
relevant tissues shift at a slower rate than the central cir-
cadian pacemaker (30). Thus, the delay in the diurnal var-
iation of SI was likely less than 3 h. If our estimations of
morning SI were affected by this modest shift of peripheral
circadian time, it would therefore be in a direction that
would result in a lower estimation of SI in the circadian
misalignment than in the circadian alignment condition.
Therefore, if affected at all by the shift of circadian time,
the difference in the decrease of SI between the two con-
ditions is underestimated, not overestimated.
We examined multiple putative mechanisms mediating
the adverse metabolic effect of circadian misalignment.
Previous studies in healthy young adults have shown that
experimental reductions of sleep quality without change
in sleep duration, by nearly complete suppression of SWS
(31) or by severe sleep fragmentation across all sleep
stages (32), can result in decreases in SI that approximate
the effect size of circadian misalignment observed in the
current study. However, the macrostructure of sleep, as
assessed in the current study by the total amounts of SWS
and REM sleep during the week of sleep restriction, was
similar in both groups. Sleep restriction did not result in
an increase in SWS in either group, and REM sleep was
markedly and similarly suppressed in both groups. There-
fore, that alterations of sleep quality played a major role
in the adverse metabolic consequences of circadian mis-
alignment seems unlikely.
Average daily caloric intake was excessive but similar in
both study groups, as were the timings of breakfast,
lunch, and dinner. However, when participants in the
circadian misalignment group were exposed to the four
shifted nights, the overnight fast was interrupted by
a small scheduled nighttime meal with continued access
to snacks during the remainder of the night. Over the
7 days of sleep restriction, the proportion of daily caloric
intake during the nighttime in the circadian misalignment
group was threefold higher than in the circadian align-
ment group. The night eating syndrome in humans
(33,34) and a shift of food intake from the active phase
to the rest phase in laboratory rodents (35,36) have been
associated with adverse metabolic consequences. Whether
the disruption of dietary intake that occurred during
shifted nights might have caused a further 20–30% de-
crease in SI compared with a normal 12-h overnight fast is
an important question with major public health implica-
tions that will need to be rigorously addressed. Impor-
tantly, weight gain was similar under both conditions,
and we verified that changes in body weight were not
a significant predictor of changes in SI or b-cell response.
The durations of exposure to light and dark were
identical in both groups, with similar levels of light
intensity during periods of wakefulness and total dark-
ness during periods of sleep. Exposure to light during
the biological night during the 4 days with bedtime periods
delayed by 8.5 h resulted in a delay of the DLMO of ;3 h
in all but two participants. The demographics and baseline
DLMO and melatonin levels of the two participants who
did not shift were similar to those of the remainder of the
group. Further, these two individuals experienced qualita-
tively and quantitatively similar changes in SI as the other
participants, suggesting that the timing of the melatonin
rhythm was not a major determinant of the metabolic
effects of circadian misalignment.
Consistent with previous studies of partial sleep de-
privation in healthy young men (37,38), sleep restriction
without circadian disruption resulted in a marked eleva-
tion of serum hsCRP levels in men. In those exposed to
circadian misalignment, the relative increase was more
than twice as large, revealing an adverse effect of circa-
dian disruption on this sensitive marker of cardiovascular
risk. Inflammation could be involved in the mechanisms
linking sleep loss and circadian disruption to alterations
in glucose metabolism.
Novel concepts regarding organization of the mamma-
lian circadian system and its interaction with metabolism
have emerged during the past 10 years (39–43). The mo-
lecular mechanism generating circadian rhythmicity
within pacemaker neurons of the SCN has been identi-
fied as a transcriptional–translational feedback loop of
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activators and repressors, including CLOCK and BMAL1 as
positive elements and PER and CRY as negative elements.
There is evidence for a direct metabolic input into the core
clock mechanism. For example, REV-ERB and RORalpha,
the products of two genes of the orphan nuclear hormone
receptor family, repress or activate, respectively, the tran-
scription of BMAL1 and contribute to the control of the
amplitude and phase of the rhythms of clock gene expres-
sion. The same interacting circuitry of core clock and met-
abolic elements is present in many peripheral tissues,
including muscle, liver, pancreas, and fat. Although the
environmental light–dark cycle is the primary synchronizer
of the central clock mechanism in the SCN, the timings of
food intake and fasting have a direct effect on peripheral
clocks. The central clock regulates behavioral rhythms, in-
cluding the sleep–wake cycle and feeding schedule, and also
entrains peripheral clocks by neural and humoral mecha-
nisms. In the current study, we created a misalignment
between the central and peripheral oscillators by imposing
an 8.5-h delay of the sleep–wake and dark–light cycles on
4 of the 7 days preceding metabolic testing. Assessment of
the DLMO, widely considered the most accurate marker of
central circadian phase (44), revealed that the central cir-
cadian signal had shifted by ;3 h at the end of the study.
Total sleep time and caloric intake were not affected
by circadian misalignment. The timing of food intake was
shifted, with a higher proportion of caloric intake occurring
during the biological night and a shorter fasting period.
When sleep opportunities were delayed by 8.5 h, peripheral
organs were exposed to nutrients during the habitual
period of overnight fast and thus received neurohormonal
inputs out of phase with central circadian signals by an
estimated 5 to 6 h. This misalignment between metabolic
cues and central circadian signals had adverse cardiometa-
bolic consequences that were not caused by reductions in
sleep duration or quality or increases in total caloric intake.
Our study was performed under carefully controlled
conditions, and the results are unequivocal. The main
limitation is the sample size. A significant sex-by-group
interaction emerged from the statistical analysis, but the
study was not powered to examine sex differences.
Findings in men were robust, with a larger-than-expected
effect size of misalignment relative to alignment.
Findings from this laboratory study provide evidence in
support of an intrinsic adverse effect of circadian mis-
alignment on glucose metabolism and cardiovascular risk.
The increased risk of diabetes and cardiovascular disease
documented in epidemiologic studies of shift work (4–9) is
thus unlikely to be solely due to sleep loss and would not be
fully mitigated by strategies designed to preserve sleep
duration.
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